Differential Expression of Fatty Acid Transport Proteins in Epidermis and Skin Appendages  by Schmuth, Matthias et al.
Differential Expression of Fatty Acid Transport Proteins in
Epidermis and Skin Appendages
Matthias Schmuth, Angelica M. Ortegon,w Mao-Qiang Man,z Peter M. Elias,z Kenneth R. Feingold,z and
Andreas Stahlw
Department of Dermatology, Innsbruck Medical University, Innsbruck, Austria; wDepartment of Medicine, Palo Alto Medical Foundation & Stanford University,
Palo Alto, California, USA; zDepartment of Veterans Affairs and University of California, San Francisco, California, USA
Epidermis and sebocyte-derived lipids are derived both from de novo synthesis and through uptake of fatty acids
from the circulation. Plasma membrane proteins can significantly contribute to the latter process. In particular,
fatty acid transport proteins (FATP/solute carrier family 27) are integral transmembrane proteins that enhance the
uptake of long-chain fatty acids into cells. Using specific antisera against all six mammalian FATP, we found that
both human and mouse skin express FATP1, -3, -4, and -6. In adult skin, FATP1 and -3 are expressed predominantly
by keratinocytes, whereas FATP4 is strongly expressed by sebaceous glands and FATP6 by hair follicle epithelia.
Sustained barrier disruption leads to increases in FATP1 and -6 levels as well as a robust increase in CD36 protein.
Notably, expression of FATP1 by embryonic keratinocytes at day 18.5 was lower, and FATP4 increased in com-
parison with adult epidermis. Together, these ﬁndings indicate that FATP are not only expressed by different cell
types within the skin, but also that their localization is dynamically regulated during development.
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A critical function of the epidermis is to provide a barrier
between the external environment and the organism. To
fulfill this function, keratinocytes undergo a complex path-
way of differentiation that culminates in keratinocyte
cornification and in the formation of extracellular lipid-
enriched lamellar membranes in the stratum corneum
(SC). These lipid-enriched membranes are primarily respon-
sible for the permeability barrier to water and electrolyte
transit. The lipid-enriched extracellular lamellar membranes
derive from the exocytosis of lamellar bodies from stratum
granulosum (SG) cells. In order for SG cells to generate
lamellar bodies, three families of lipids, specifically choles-
terol, phospholipids, and glucosylceramides, must be gen-
erated at sufficient levels in SG cells (Grubauer et al, 1987;
Elias and Feingold, 1988; Feingold and Elias, 1999). A fur-
ther requirement is that these lipids must be generated at
appropriately 1:1:1 molar ratios or abnormal lamellar bodies
are formed and barrier dysfunction results. Previous studies
have demonstrated that the epidermis is a very active site of
lipid synthesis (Nicolaides and Rothman, 1955; Brooks et al,
1966; Hsia et al, 1966; Wilkinson, 1970; Grubauer et al,
1987; Feingold et al, 1991), and that inhibition of cholesterol,
fatty acid, ceramide, or glucosylceramide synthesis blocks
lamellar body formation (Feingold et al, 1990; Holleran et al,
1991; Man et al, 1993; Chujor et al, 1998; Schmuth et al,
2000). Lipid synthesis also occurs in the keratinocytes of the
hair follicle, where it fluctuates in relation to the hair cycle.
Anagen is associated with increased cholesterol and tri-
glyceride content, whereas fatty acid content decreases
during anagen (Carruthers, 1962; Carruthers and Heining,
1963; Brooks et al, 1966).
Epidermal fatty acids derive not only from de novo syn-
thesis in the epidermis but fatty acids can also be derived in
part from extracutaneous sites (Grubauer et al, 1987; Fe-
ingold, 1991). First, essential fatty acids are required for
normal permeability barrier function but by definition these
fatty acids are not synthesized and therefore they must be
derived from the diet (Miller et al, 1989). For example, lino-
leate acid must be derived from the circulation and as the
epidermis lacks both the delta 5 and delta 6 desaturases
(Chapkin and Ziboh, 1984) it consequently cannot convert
linoleate to arachidonic acid, which therefore must also be
obtained from other sites. Additionally, C22:6, n3 (eicosa-
pentaenoic acid) and C20:5, n3 (docosahexaenoic acid)
fatty acids derived from the ingestion of dietery fish oil are
incorporated into epidermal lipids (Ziboh et al, 1986). Sec-
ond, plant-derived fatty acids accumulate in the epidermis
in certain disease states, such as Refsum’s disease (Klenk
and Kahike, 1963; Foulon et al, 2003). Third, our studies
have shown that systemically administered 14C-labeled
fatty acids are delivered to the epidermis (Grubauer et al,
1987). Fourth, although inhibition of epidermal fatty acid
synthesis perturbs permeability barrier recovery following
acute disruption, the degree of inhibition is relatively modest
(Man et al, 1993), suggesting that other sources of fatty
acids are available to the epidermis for lamellar body
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synthesis. Fifth, studies have shown the active uptake of
fatty acids by keratinocytes. Fatty acid uptake by keratin-
ocytes is temperature sensitive, has saturable kinetics, and
can be reduced by prior treatment with trypsin, indicating
that plasma membrane proteins mediate fatty acid transport
(Schurer et al, 1994).
Human sebaceous glands secrete an oily sebum con-
sisting of triglycerides, fatty acids, wax monoesters,
squalene, cholesterol, and cholesterol esters. Although ker-
atinocyte-derived lipids form the permeability barrier, the
lipid metabolites secreted by sebaceous glands are depos-
ited at the skin surface and are important for SC hydration
and water repulsion. Sebaceous glands have been reported
to express the enzymes that catalyze cholesterol, fatty acid,
and triglyceride biosyntheses, namely 3-hydroxy-3-methyl-
glutaryl-coenzyme A reductase and acetyl-coenzyme (CoA)
carboxylase (Smythe et al, 1998), fatty acid synthase, fatty
acid desaturase, medium chain acyl-CoA dehydrogenase,
squalene synthase, farnesyl transferase (Cooper et al, 1976;
Cassidy et al, 1986; Thiboutot et al, 2003), and acyl-CoA:
diacylglycerol acyltransferase (DGAT1, DGAT2) (Chen et al,
2002; Stone et al, 2004). Mutations in the stearoyl-CoA
desaturase 1 (scd1) which catalyzes the biosynthesis of
monounsaturated fatty acids, are the underlying cause for
sebaceous gland ablation in asebia mice (Zheng et al, 1999;
Lu et al, 2004). Furthermore, the fatty acid chain elongation
enzyme LOVL3 participates in the formation of neutral lipids
in sebaceous glands (Westerberg et al, 2004).
Although it is not known if and how fatty acids are trans-
ported into hair follicles and sebocytes, previous studies
have demonstrated active fatty acid uptake in epidermal
keratinocytes and in a variety of other organs, including
muscle (Kim et al, 2004), heart (Sorrentino et al, 1988;
Stremmel, 1989a), adipocytes (Stump et al, 2001), liver
(Stremmel, 1989b), and small intestine (Stremmel, 1988;
Gore and Hoinard, 1993). Several proteins that can increase
cellular uptake of long-chain fatty acids (LCFA) have been
identified by biochemical means and by expression cloning,
and include the scavenger receptor fatty acid translocase
(CD36), an integral membrane protein well studied for its
role in fatty acid uptake by cells (Brinkmann et al, 2002;
Ibrahimi and Abumrad, 2002), mitochondrial aspartate ami-
no transferase (FABPpm) (Berk et al, 1990), and fatty acid
transport proteins (FATP/solute carrier family 27) (Stahl,
2004). FATP are integral transmembrane proteins (Lewis
et al, 2001) that enhance the uptake of LCFA and very LCFA
into cells (Stahl, 2004). FATP in humans and mice comprise
a family of six highly homologous proteins, FATP16, which
are found in all fatty acid utilizing tissues of the body, in-
cluding the skin (Stahl, 2004). FATP4 has recently been im-
plicated in skin development and barrier function. Although
targeted deletion of FATP4 exons 1 and 4 resulted in em-
bryonic lethality (Gimeno et al, 2003), two other reports
showed that mouse strains with FATP4 loss of function be-
cause of either a spontaneous transposon insertion in exon
3 (Moulson et al, 2003), or targeted disruption of exon 3 via
homologous recombination (Herrmann et al, 2003) are via-
ble at birth; however, both groups reported that FATP4 null
mice die within days after birth because of a phenotype
reminiscent of restrictive dermopathy with tight, wrinkle-free
skin, and disrupted skin barrier function. How partial abla-
tion of FATP4 causes this skin phenotype and where FATP
are expressed in embryonic and adult skin is unknown.
To investigate the principle fatty acid transporters that
facilitate the uptake of fatty acids in the skin during periods
of barrier maintenance, re-establishment, and initial forma-
tion, we determined the localization and expression of
FATP1–6 in mouse and human skin in comparison with
CD36. We observed constitutive expression FATP1 and -3 in
epidermal keratinocytes, FATP4 in sebaceous glands, and
FATP6 in the hair follicle. The distribution of FATP expres-
sion was altered both during fetal skin development and
when the epidermal barrier was exposed to sustained en-
vironmental stress, i.e., the removal of SC lipids by acetone,
resulting in sustained barrier disruption. Together, these
findings may indicate differential lipid requirements in var-
ious compartments of the skin that are met by the presence
of multiple transporters with selective specificity. If this sys-
tem is environmentally challenged during fetal development
or by environmental stress, FATP distribution is altered,
presumably aimed at maintaining the steady state of lipid
compartmentalization in the epidermis.
Results
Murine epidermis and appendages express multiple
FATP proteins To determine which FATP proteins are
present in mouse epidermis, epidermal lysates from two
adult mice were separated by SDS PAGE and probed with
antibodies specific for FATP1–6. FATP1, -3, and -4 showed
robust expression, FATP6 was weakly expressed and
FATP2 and -5 were not detectable (Fig 1A). Control exper-
iments with equal amounts of liver lysates showed strong
expression of FATP2 and -5 (data not shown), demonstrat-
ing that the results reflected a true lack of FATP2 and -5
protein expressions in the epidermis. Using immunofluo-
rescence microscopy, FATP1 was robustly expressed by
keratinocytes both within the interfollicular epidermis and in
a follicular distribution within the dermis (Fig 1B). FATP3 in
mouse skin was heavily expressed by epidermal keratin-
ocytes (Fig 1B). FATP4 was less prominently expressed by
epidermal and hair follicle keratinocytes, but strongly asso-
ciated with sebaceous glands (Fig 1B). This notion was
confirmed by our finding that dermal FATP4 staining of
sebaceous glands in murine and human (data not shown)
skin co-localized with Nile Red positive, neutral lipid-rich
structures (Fig 1C). FATP6 in mouse skin was again asso-
ciated with both interfollicular and follicular keratinocytes
(Fig 1B). As expected from our western blot studies
no staining for FATP2 or -5 was observed in mouse skin
(Fig S1). Surprisingly, CD36, which previously had been re-
ported to be expressed in epidermis (Lisby et al, 1990),
showed only a very weak signal that was close in intensity
and distribution to background (Fig 1B). The results
for murine FATP expression within the epidermis are
summarized in Table I.
Changes in FATP expression following sustained bar-
rier disruption To determine whether FATP expression
is static or whether one or more proteins are affected by
environmental and/or developmental changes, we next
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compared the expression patterns of these proteins in nor-
mal mouse skin with mouse skin obtained following barrier
disruption. Although immunofluorescent studies of mouse
skin 3 h after tape stripping (acute barrier disruption) did not
reveal any differences versus non-tape stripped control an-
imals, sustained barrier disruption by acetone treatment for
3 d demonstrated changes in FATP localization. Although
FATP3 and -4 appeared unchanged after barrier disruption,
FATP1 showed a more pronounced staining of structures in
the dermis (Fig 2A). Acetone treatment did not alter the
overall distribution of FATP6 but resulted in an increase in
the amount of FATP6 protein in epidermis versus hair fol-
licles (Fig 2A). Most notably, CD36 was expressed only at
very low levels in normal mouse skin but was strongly up-
regulated in both dermal and epidermal layers after barrier
disruption (Fig 2A). This increase in CD36 protein agrees
with our previous studies that demonstrated an increase in
CD36 mRNA levels following barrier perturbation (Harris
et al, 1998).
FATP expression changes late in fetal development Fat-
ty acid synthesis and utilization peaks during the later stages
Figure 1
Expression and localization of fatty acid
transporter proteins (FATP) in mouse
skin. (A) Western blot of two different murine
epidermal lysates with antisera against all
six FATP family members. (B) Immunofluo-
rescence images of mouse skin with or
without phase contrast for pre-immune se-
rum (control), FATP1–6 antisera, and for anti-
CD36. (C) FATP4 localization (green) in
mouse skin co-stained for neutral lipids us-
ing Nile Red (red). Fluorescence for each
channel, their overlay, and a phase contrast
image are shown. Red size bar equals 50 mm
in all images.
Table I. Summary of murine fatty acid transporter expression in skin
FATP1 FATP2 FATP3 FATP4 FATP5 FATP6 CD36
Upper epidermis þ þ  þ þ þ þ  þ 
Lower epidermis þ þ  þ þ þ   þ
Sebaceous glands    þ þ þ   
Hair follicles þ  þ þ  þ þ þ þ
Subcutaneous fat þ þ þ   þ þ þ   þ
Expression, assessed by immunofluorescence staining, in the indicated areas of skin was scored for signal strength.
, undetectable; þ , weak expression; þ þ , robust expression; þ þ þ , strong expression; FATP, fatty acid transport proteins.
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of epidermal development (Hurt et al, 1995), presumably in
preparation for terrestrial life. Therefore, we next compared
the adult expression pattern of FATP with their embryonic
expression at day 18.5 in mouse embryos. Surprisingly, we
found that FATP1 is not expressed by embryonic keratin-
ocytes (Fig 2BaI) but it is robustly expressed by subcuta-
neous adipocytes (Fig 2BaII). FATP3 was expressed in the
epidermis of day 18.5 embryos as it is in adult skin, but there
was preferential basal staining (Fig 2Bb). Targeted deletion of
exon 3 of FATP4 has been reported to result in neonatal
lethality because of skin abnormalities (Herrmann et al, 2003)
but FATP4 expression in adult skin is predominantly in se-
baceous glands (Fig 1B). By contrast, we found that FATP4
in day 18.5 embryonic skin was not only expressed through-
out the dermis but also to a lesser extent by the basal layer
of epidermal cells adjacent to the basolateral membranes
(Fig 2Bc). Finally, FATP6 was expressed by cells within
embryonic hair follicles and, less prominently, by epidermal
keratinocytes (Fig 2Bd). These findings reveal dynamic
changes of FATP expression in embryonic skin that may re-
flect the generation of lipid compartmentalization during
development.
FATP expression in human skin is comparable with that
in mice Next, we stained human skin either with a control
serum (non-immunized rabbit), sera specific for FATP1, -3,
-4, and -6 or with a monoclonal antiserum against CD36.
FATP1 and -3 had similar staining patterns showing ex-
pression of the transporters by epidermal keratinocytes (Fig
3A). Both FATP1 and -3 appeared to be more prominent on
the baso-lateral side of cells. In contrast to mouse skin,
there was no FATP1 staining in human dermis. FATP4
stained keratinocytes only moderately but it was robustly
expressed by sebaceous glands (Fig 3A), where it again co-
localized with Nile Red (data not shown). Human FATP6
showed weak staining of the epidermal layer but, as in
mouse skin, it was strongly expressed in hair follicles. CD36
expression approximated the lower detection limit appear-
ing as diffuse staining throughout the dermis (Fig 3A).
In primary cultures of human keratinocytes, the primary
expressed FATP was FATP4 (Fig 3B). Upon induction of
differentiation by switching the calcium concentration in the
culture medium from 0.07 to 1.2 mM, FATP4 expression
was downregulated (Fig 3B). Importantly, neither FATP1,
-3, nor -6 were expressed in either undifferentiated or
differentiated human keratinocytes in marked contrast to
human and mouse epidermis. Finally, FATP2 and -5 were
absent from both human keratinocytes and skin.
Discussion
The epidermis is a very active site of lipid synthesis, ex-
ceeding even the liver, kidneys, and GI epithelia on a per
weight basis (Feingold, 1991). Keratinocytes require fatty
acids as substrates for the formation of phospho- and
sphingolipids, which are key components of the lipid-enriched
lamellar bodies. These specialized organelles secrete their
content to the extracellular space, thus meeting the special
requirements for non-essential fatty acids, derived from the
hydrolysis of phospholipids, as key components of the ex-
tracellular lamellar membranes. In addition, the epidermis
has separate structural requirements for linoleate acid as
a critical moiety in unique ceramides (omega-hydroxyl
Figure 2
Modulation of fatty acid transporter pro-
teins (FATP) expression following barrier
disruption and during development. (A)
Immunofluorescence images of mouse
skin with or without phase contrast for
FATP1–6 and CD36 following sustained
barrier disruption by acetone treatment
for 3 d. Red size bar equals 50 mm. (B)
FATP localization in day 18.5 embryonic
skin. FATP1-specific staining (a) in the ep-
idermis (I) and subcutaneous fat (II) as well
as FATP3 (b), FATP4 (c), and FATP6 (d) lo-
calization in the skin are shown. DAPI-
stained nuclei are shown in blue. Red size
bar equals 20 mm.
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ceramides, with o-acylated linoleate acid), which are essen-
tial for linking the bilayers together and providing anchors of
the membrane system to the external surface of the corni-
fied envelope of the corneocyte scaffold. Indeed, epidermal
lipids comprise considerable quantities of ceramides that
contain very long-chain N-acylated fatty acids (C24-30).
Although keratinocytes exhibit elongase activity, they may
also try to import some of the very long-chain species
from the blood. In addition to this structural role, epidermal
fatty acids also serve as an energy source and as signal-
ing molecules, modulating keratinocyte proliferation and
differentiation.
Despite its great synthetic capacity, several lines of ev-
idence indicate that fatty acids are not solely derived from
de novo synthesis within the epidermis, suggesting that at
least a proportion of these lipids must be imported from
extra-cutaneous sites. Epidermis lacks not only delta 5, but
also delta 6 desaturase, so it must not only import linoleate,
but also arachidonate acid. Our knowledge of the pathways
of fatty acid transport in keratinocytes is incomplete. It al-
ready is clear that fatty acid uptake by keratinocytes does
not only occur passively, via a non-energy-dependent plas-
ma membrane flip/flop mechanism, but instead fatty acid
transport is carrier mediated. For example, previous studies
by our laboratory have reported that FATP, FABP-pm, and
CD36/FAT are expressed in epidermis/keratinocytes (Harris
et al, 1998). Here, we present a comprehensive analysis of
FATP expression, localization, and regulation in skin. We
report expression of four different FATP, FATP1, -3, -4, and -
6 in both human and mouse skin (see Table I). This is to our
knowledge the largest number of plasma membrane fatty
acid transporters expressed in a single organ and clearly
reflects the importance of exogenous LCFA uptake for the
skin. FATP1 has previously been shown to be expressed by
adipocytes, muscle, and brain (Schaffer and Lodish, 1994;
Schaap et al, 1997; Hirsch et al, 1998; Coe et al, 1999;
Binnert et al, 2000; Stahl, 2004). FATP3 is expressed in a
variety of tissues, most notably the lung (Stahl et al, 2001),
FATP4 is the principle fatty acid transporter in the small
intestine and is also present in adipocytes, muscle, and
brain (Stahl et al, 1999), whereas FATP6 is highly expressed
by the heart (Gimeno et al, 2003). Why does the skin need
such a multitude of FATP? Although no differences in FATP
substrate specificity have thus far been reported (Stahl,
Figure3
Localization of fatty acid transporter pro-
teins (FATP) in human skin and cultured
keratinocytes. (A) Immunofluorescence im-
ages of mouse skin with or without phase
contrast for pre-immune serum (control),
FATP1–6 antisera, and for anti-CD36. Red
size bar equals 50 mm. (B) Densitometric
quantification of FATP expression in four in-
dependent lysates from undifferentiated
(white bars) and differentiated (black bars).
Error bars indicated standard deviation of
mean.
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2004), one obvious difference lies in the cell types that
express the transporters, i.e., interfollicular keratinocytes
(FATP1 and -3), hair follicle epithelials (FATP6), and seba-
ceous glands (FATP4).
In the epidermis, lipids have important structural impli-
cations. The extracellular deposition of lamellar membranes
in the SC is responsible for the permeability barrier to water
and electrolyte transit (Elias and Feingold, 1988). These la-
mellar membranes are essential for life in an arid, terrestrial
environment because they prevent excess evaporation of
body fluids and conversely they protect the body from po-
tential outside threats of physical, chemical, or biological
nature. Three families of lipids, cholesterol, phospholipids,
and glucosylceramides, must be generated at sufficient
levels in specialized cell organelles, the lamellar bodies, of
SG cells within the epidermis. Our previous studies showed
an increase in fatty acyl-CoA synthase mRNA and activity in
response to barrier disruption, which suggests a role in re-
storing normal SC function after external insults (Harris et al,
1998). The increase in epidermal FATP6, dermal FATP1, and
both epidermal and dermal CD36 after barrier disruption
reported here may also reflect the formation of lamellar
membranes, aimed at restoring the permeability barrier
function. Yet, this increase was only detectable in the set-
ting of sustained barrier disruption (3 consecutive d of re-
petitive acetone treatment), but not after acute barrier
disruption. These findings indicate that the FATP are in-
volved in restoring the steady state of epidermal lipid com-
partmentalization and metabolism after the cellular stores
have been exhausted, rather than being involved in the
acute repair response.
The scavenger receptor CD36 is known to be increased
in hyperproliferative skin (sustained barrier disruption by
acetone treatment for 3 d induces epidermal hyperplasia) as
well as in other inflammatory skin disorders such as atopic
dermatitis, irritant dermatitis, psoriasis, and following
wounding (Harris et al, 1998). Weak staining under base-
line conditions and inducibility in response to external in-
sults may indicate the involvement of CD36 in epidermal
homeostasis. CD36 could be important for both secretion
and processing of epidermal lipoproteins. In addition, CD36
appears to be involved in other cellular functions such as
cell adhesion, angiogenesis, and immune function. Thus,
the increase in CD36 could also reflect an increase in immu-
nosurveillance of barrier disrupted skin because, aside
from serving as a receptor for lipid uptake, CD36 is ex-
pressed in cutaneous macrophages and in Langerhans, and
barrier disruption has been linked to an activation of the
immune system both by stimulating the release of inflam-
matory mediators and by activation of the cellular immune
system (Wood et al, 1992; Nishijima et al, 1997; Jensen et al,
1999; Schmuth et al, 2002).
Our finding that FATP6 is expressed by hair follicles is
interesting and surprising. We have shown previously that
out of 16 different tissues (which did not include skin) only
the heart showed significant expression of FATP6 (Gimeno
et al, 2003). Although it is known that the hair follicle is
metabolically very active during anagen, it is unclear which
requirements could be shared by the heart and the hair
follicle, and only little information is available on the role of
lipids in hair cycling and development (Carruthers, 1962;
Carruthers and Heining, 1963; Brooks et al, 1968). A recent
study, however, reported markedly decreased amounts of
wax diesters associated with hair loss and atrophy of se-
baceous glands in mice deficient in acyl CoA:diacylglycerol
acyltransferase (DGAT1) (Chen et al, 2002). Wax esters,
which are derived from fatty acids, together with triglycer-
ides, comprise the main lipid fraction secreted by seba-
ceous glands. In this study, FATP4 was strongly expressed
in sebaceous glands. In hair follicles, FATP may supply the
energy sources as hair has cholesterol, cholesterol sulfate,
and LDL receptors. Also, hair has intrinsic lipids, including
an unusual fatty acid—18-methyleicosanoic acid (Jones and
Rivett, 1997). The reason for the differences in transporters
could be that different fatty acids are required in different
sites. Substrate specificity of transporters may be the basis
for the need for multiple transporters. Another possibility is
that each transporter could deliver the fatty acid to a dif-
ferent intracellular location, for example, preferential trans-
port to the mitochondria to be utilized for energy versus to
ER to be utilized in formation of TG/PL, etc.
Deletion of FATP4 exon 3 results in neonatal lethality from
a phenotype reminiscent of restrictive dermopathy with
hyperkeratosis and disturbed epidermal barrier function
(Herrmann et al, 2003; Moulson et al, 2003). The results
presented here show that although FATP4 in adult human
and mouse skin is predominantly expressed by cells of the
sebaceous glands, embryonic expression of FATP4 is high
in keratinocytes and throughout the dermis. Using a poly-
clonal anti FATP4 peptide serum Herrmann et al (2003) also
reported FATP4 expression by neonatal keratinocytes but
failed to detect expression in the dermal layer. This differ-
ence could be possibly because of changes between day
18.5 and early postnatal stages or because of the fact that
we used saponin to achieve better tissue penetration,
whereas the former study was done without detergents. The
effect of FATP4 loss on keratinocytes during embryonic de-
velopment could be further impacted by the absence of the
highly homologous transporter FATP1 during development.
The fact that FATP1 seems to be expressed only at later
stages could also explain why FATP1 null mice show no
similar phenotype to FATP4 null mice and have no
reported skin abnormalities (Kim et al, 2004). Meanwhile
expression of FATP4 during early development seems to be
vital, its role in adult skin remains to be determined. Al-
though to date no regulatory abnormalities or mutations in
FATP have been described in skin disease, these findings
broaden our understanding of the mechanisms underlying
normal skin function and provide seminary observations for
future evaluations of FATP as targets for the diagnosis and
therapy of skin disorders.
Materials and Methods
Antibodies Rabbit polyclonal antibodies against FATP1, -4, and
-6 were generated as previously described (Stahl et al, 1999, 2002;
Gimeno et al, 2003). Similarly, FATP2, -3, and -5 anti-sera were
raised by immunizing rabbits with the last 90 C-terminal amino
acids of the respective FATP fused to glutathione S-transferase.
Serum was affinity purified over protein A columns and found to
have minimal cross-reactivity against other FATP family members.
The anti-CD36 monoclonal antibody was a generous gift from Dr
Maria Febbraio.
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Sources of skin specimens Animals employed in these studies
include hairless mice (hr/hr), C57BL/6, and Sv129 (Simonsen
Laboratories, Gilroy, California). Adult animals were sacrificed by
inhalation anesthesia followed by cervical dislocation at the indi-
cated time points and skin was further processed for western blot
or immunofluorescence microscopy. All studies involving animals
were approved by the institutional review boards. To determine
FATP expression during fetal development, in some experiments
pups were delivered by cesarean section on day 18.5 of gestation.
Human skin specimens were derived from archival material.
Epidermal permeability barrier function Permeability barrier
function was determined by measuring transepidermal water loss
(TEWL) with an electronic water analyzer (MEECO, Warrington,
Pennsylvania). Acute barrier disruption was induced by sequential
tape stripping until TEWL reached 6–8 mg per cm2 per h. Sus-
tained barrier disruption was induced in hairless mice by twice
daily application of acetone-soaked cotton balls until the TEWL
reached 6–8 mg per cm2 per h for 3 consecutive days (Komuves
et al, 2000). Skin specimens were obtained after 3 h and on day 4,
respectively, and processed for immunofluorescence microscopy.
Cell culture Second-passage keratinocytes isolated from new-
born foreskins were cultured in serum-free keratinocyte growth
medium (KGM; Clonetics, San Diego, California). Differentiation
was induced in these cells by switching the calcium concentration
in the culture medium from 0.07 to 1.2 mM and cells were har-
vested after 48 h at 70%–100% confluency.
Western blot analysis Subcutaneous fat was removed from the
skin specimen, and the epidermis was separated from the dermis
after incubation in 10 mM EDTA-phosphate-buffered saline (PBS)
for 40–50 min. The tissue was then homogenized in ice cold RIPA
buffer (150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50 mM
Tris pH 8.0) and western blots were performed as previously de-
scribed (Stahl et al, 2002).
Immunoﬂuorescence microscopy Unfixed mouse skin was re-
moved by surgical excision, washed in PBS, and embedded in
O.C.T. 4583 compound. The material was thick sectioned (15–40
mm). The sections were washed in PBS containing 1% BSA, 10%
fetal calf serum, and 1% normal donkey serum (blocking solution)
to block non-specific binding. Primary antibodies were diluted in
blocking solution incubated for 1 h and washed extensively with
blocking solution for 30 min. Incubation and washing steps for
secondary antibodies was identical. Finally, sections were rinsed
with PBS and mounted in 90% glycerol/PBS containing 1 mg per
mL paraphenylinediamine, and examined with a Zeiss LSM510
confocal system. Nile Red staining were performed as previously
described (Fowler and Greenspan, 1985).
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the preparation of the manuscript. This work was supported by a grant
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